On December 26, 2023, Shanghai Vcanbio Jisheng Cell Technology Co., Ltd. closed the transaction. The company's registered capital increased by CNY 20 million post-completion of the transaction.
Vcanbio Cell & Gene Engineering Corp., Ltd
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.87 CNY | +10.01% | +22.87% | +7.89% |
1st Jan change | Capi. | |
---|---|---|
+7.89% | 1.27B | |
-1.34% | 12.58B | |
-1.64% | 8.51B | |
+0.09% | 5.29B | |
+22.42% | 5.16B | |
-0.09% | 4.55B | |
-52.84% | 3.04B | |
+20.02% | 3B | |
+31.92% | 2.17B | |
-2.45% | 1.92B |
- Stock Market
- Equities
- 600645 Stock
- News Vcanbio Cell & Gene Engineering Corp., Ltd
- Shanghai Vcanbio Jisheng Cell Technology Co., Ltd. announced that it has received CNY 20 million in funding from Vcanbio Cell & Gene Engineering Corp., Ltd